Admittance Technologies is the brainchild of Marc D. Feldman, M.D. It is an early stage, Austin, TX based company committed to delivering electrical engineering solutions to heart failure patients. Admittance’s IP portfolio and engineering prototypes are the evolution of a collaborative research program at The University of Texas on both the San Antonio and Austin campuses for the last 14 years. The research produced by these groups has been published in multiple journals, resulted in 9 patents either issued or pending dating as far back as 1998, and sales of over 150 animal systems to date via our industry partner, Transonic Scisense Inc., in Canada.
Admittance Technologies is committed to improving the quality of life of patients with heart disease through innovative electrical engineering solutions.